Access Statistics for Patricia M. Danzon

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality 0 0 0 388 2 4 17 1,172
Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets 0 1 1 66 0 5 9 199
Effects of Regulation on Drug Launch and Pricing in Interdependent Markets 0 0 2 243 0 1 13 786
Mandated Employment-Based Health Insurance:Incidence and Efficiency Effects 0 0 0 1 0 0 1 460
Mergers and Acquisitions in the Pharmaceutical and Biotech Industries 1 3 7 1,473 3 10 50 4,499
Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement 0 0 0 96 1 2 6 187
Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution? 0 0 2 2 1 1 5 8
Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy 0 0 1 95 1 1 3 338
Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances 0 0 0 538 2 3 12 1,949
Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand 0 1 2 350 4 14 37 1,108
The Effects of Malpractice Litigation on Physicians' Fees and Incomes 0 0 0 0 0 1 3 670
The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s 0 0 1 288 2 3 13 749
Vaccine Supply: Effects Of Regulation And Competition 0 0 0 19 2 4 17 124
Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context 0 0 2 53 3 3 14 141
Total Working Papers 1 5 18 3,612 21 52 200 12,390


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
"Crises" in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market 0 0 0 38 0 2 4 181
A general model of the impact of absenteeism on employers and employees 0 0 1 139 1 1 14 678
A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth 0 0 0 14 0 0 2 52
Alternative Liability Regimes for Medical Injuries 0 0 0 1 0 0 1 12
Comments on "The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions." 0 0 0 0 0 0 2 287
Contingent Fees for Personal Injury Litigation 0 0 0 80 0 3 9 857
Cross-national price differences for pharmaceuticals: how large, and why? 0 0 6 291 0 2 18 664
Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues 0 0 2 3 1 2 14 20
Does Regulation Drive out Competition in Pharmaceutical Markets? 0 0 1 24 0 2 8 1,122
Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion 0 0 0 69 0 1 3 202
Health Care Reform 0 0 0 4 0 0 0 23
Health Insurance and the Growth in Pharmaceutical Expenditures 0 0 0 11 0 0 2 50
Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment 0 0 0 3 0 0 1 238
Hospital `profits': The effects of reimbursement policies 0 0 0 35 0 0 1 136
Liability and liability insurance for medical malpractice 0 0 0 56 0 1 2 163
Liability for Medical Malpractice 0 0 2 196 1 2 11 660
Medical negligence and the NHS: an economic analysis 0 0 0 0 1 1 2 155
Mergers and acquisitions in the pharmaceutical and biotech industries 0 1 3 319 7 10 28 1,004
Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement 0 0 1 4 0 1 5 35
Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive? 0 0 1 9 0 0 2 29
Price Cutting in Liability Insurance Markets 0 0 1 106 2 2 5 458
Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU 0 0 9 141 1 3 25 365
Price, Financial Quality, and Capital Flows in Insurance Markets 0 0 1 113 2 4 19 364
Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances 0 0 1 118 3 6 20 537
Rate Regulation, Safety Incentives, and Loss Growth in Workers' Compensation Insurance 0 0 0 77 0 1 2 648
Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand 0 0 3 73 2 11 35 397
Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00 0 3 14 74 0 5 33 260
Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95 0 0 0 5 0 1 1 16
Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50 0 0 1 5 0 0 4 40
Separation of the redistributive and allocative functions of government: A public choice perspective 0 0 0 67 0 0 0 462
The Economic Implications of Public Disability Insurance in the United States 0 0 0 46 0 0 5 199
The Effects of Malpractice Litigation on Physicians' Fees and Incomes 0 0 0 53 0 0 7 183
The Frequency and Severity of Medical Malpractice Claims 0 0 0 5 0 0 2 591
The Political Economy of Workers' Compensation: Lessons for Product Liability 0 0 1 8 0 0 2 62
The Swedish patient compensation system: Myths and realities 0 0 0 93 0 0 2 218
The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s 0 0 3 83 2 3 12 330
Tort Liability: A Minefield for Managed Care? 0 0 0 0 0 0 0 230
Tort Reform: The Case of Medical Malpractice 0 0 0 0 0 0 1 448
Vaccine Supply: Effects of Regulation and Competition 0 0 0 22 2 3 13 164
Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context 0 1 4 20 1 5 22 95
Welfare effects of supplementary insurance: a comment 0 0 0 25 0 0 0 73
Worker's Compensation Rate Regulation: How Price Controls Increase Costs 0 1 1 1 0 1 2 426
Total Journal Articles 0 6 56 2,431 26 73 341 13,134


Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison 0 2 2 7 1 3 16 35
The Life Cycle of Pharmaceuticals: A Cross-National Perspective 0 0 0 1 1 5 10 20
Trade and Price Differentials for Pharmaceuticals: Policy Options 0 0 4 12 0 0 24 49
Total Books 0 2 6 20 2 8 50 104


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Liability for medical malpractice 0 2 14 637 6 20 133 3,099
Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand 0 0 1 42 1 17 28 163
Regulation of the Biopharmaceutical Industry 0 0 0 8 0 0 0 12
Regulation of the Pharmaceutical-Biotechnology Industry 2 3 8 142 5 7 30 403
The Effects of Price Regulation on Productivity in Pharmaceuticals 0 0 0 21 1 1 4 66
Total Chapters 2 5 23 850 13 45 195 3,743


Statistics updated 2020-09-04